Trexquant Investment’s Dermira, Inc. DERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-17,177
| Closed | -$260K | – | 1579 |
|
|
2019
Q4 | $260K | Buy |
+17,177
| New | +$148K | 0.02% | 808 |
|
|
2019
Q3 | – | Sell |
-13,590
| Closed | -$130K | – | 1230 |
|
|
2019
Q2 | $130K | Buy |
+13,590
| New | +$146K | 0.01% | 731 |
|
|
2019
Q1 | – | Sell |
-31,434
| Closed | -$226K | – | 1456 |
|
|
2018
Q4 | $226K | Buy |
31,434
+17,021
| +118% | +$186K | 0.01% | 875 |
|
|
2018
Q3 | $157K | Sell |
14,413
-17,162
| -54% | -$173K | 0.01% | 859 |
|
|
2018
Q2 | $290K | Buy |
+31,575
| New | +$294K | 0.02% | 692 |
|
|
2018
Q1 | – | Sell |
-15,982
| Closed | -$444K | – | 1524 |
|
|
2017
Q4 | $444K | Buy |
+15,982
| New | +$424K | 0.05% | 566 |
|
|
2016
Q4 | – | Sell |
-6,127
| Closed | -$207K | – | 1219 |
|
|
2016
Q3 | $207K | Buy |
+6,127
| New | +$197K | 0.05% | 631 |
|
|
2016
Q2 | – | Sell |
-52,268
| Closed | -$1.08M | – | 1219 |
|
|
2016
Q1 | $1.08M | Buy |
52,268
+35,275
| +208% | +$866K | 0.13% | 270 |
|
|
2015
Q4 | $588K | Buy |
+16,993
| New | +$488K | 0.05% | 621 |
|
Trexquant Investment's DERM Position: Q1 2020 in Review
Trexquant Investment sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 17,177 shares — an estimated $260K sold.
Trexquant Investment first reported a position in DERM in Q4 2015 and held it in 9 quarters. The position peaked at $1.08M in Q1 2016. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.
- Trexquant Investment reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
- Trexquant Investment sold 17,177 Dermira, Inc. shares in Q1 2020, an estimated $260K.
- Trexquant Investment first reported a position in Dermira, Inc. in Q4 2015 and held it in 9 quarters.
- Trexquant Investment's Dermira, Inc. position peaked at $1.08M in Q1 2016.
- 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.
Based on Trexquant Investment's 13F filing for Q1 2020, filed 8 May 2020.